Acadian Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$289K Hold
9,174
﹤0.01% 1245
2025
Q1
$300K Buy
9,174
+6,934
+310% +$227K ﹤0.01% 1180
2024
Q4
$80K Buy
2,240
+877
+64% +$31.3K ﹤0.01% 1394
2024
Q3
$42K Buy
+1,363
New +$42K ﹤0.01% 1848
2021
Q2
Sell
-13,258
Closed -$347K 2200
2021
Q1
$347K Sell
13,258
-165,331
-93% -$4.33M ﹤0.01% 1319
2020
Q4
$4.49M Sell
178,589
-238,872
-57% -$6.01M 0.02% 526
2020
Q3
$8.7M Sell
417,461
-253,454
-38% -$5.28M 0.04% 337
2020
Q2
$15.9M Buy
670,915
+250,467
+60% +$5.95M 0.07% 249
2020
Q1
$7.57M Buy
420,448
+1,519
+0.4% +$27.3K 0.04% 309
2019
Q4
$9.94M Sell
418,929
-108,646
-21% -$2.58M 0.05% 304
2019
Q3
$14.5M Sell
527,575
-60,826
-10% -$1.67M 0.06% 265
2019
Q2
$19.5M Sell
588,401
-145,997
-20% -$4.83M 0.09% 192
2019
Q1
$25.7M Buy
734,398
+9,364
+1% +$328K 0.11% 176
2018
Q4
$24.1M Sell
725,034
-147,856
-17% -$4.91M 0.12% 165
2018
Q3
$44M Sell
872,890
-249,115
-22% -$12.5M 0.18% 126
2018
Q2
$67.2M Sell
1,122,005
-18,414
-2% -$1.1M 0.29% 91
2018
Q1
$52.2M Sell
1,140,419
-139,760
-11% -$6.4M 0.23% 101
2017
Q4
$51M Buy
1,280,179
+24,491
+2% +$976K 0.22% 107
2017
Q3
$50.2M Sell
1,255,688
-301,856
-19% -$12.1M 0.22% 109
2017
Q2
$67.1M Sell
1,557,544
-63,254
-4% -$2.73M 0.3% 89
2017
Q1
$50.7M Sell
1,620,798
-41,301
-2% -$1.29M 0.23% 106
2016
Q4
$42M Sell
1,662,099
-75,427
-4% -$1.9M 0.2% 114
2016
Q3
$43M Buy
1,737,526
+210,249
+14% +$5.2M 0.21% 123
2016
Q2
$31.1M Buy
1,527,277
+67,870
+5% +$1.38M 0.16% 142
2016
Q1
$22.3M Sell
1,459,407
-173,276
-11% -$2.64M 0.11% 188
2015
Q4
$21.9M Buy
1,632,683
+913,129
+127% +$12.3M 0.11% 192
2015
Q3
$10.1M Buy
719,554
+116,534
+19% +$1.64M 0.06% 287
2015
Q2
$10.2M Buy
+603,020
New +$10.2M 0.05% 286